Evidence map›Paper›PMID 26077038›Full record

Trial reportRespiratory medicine2015

Moderate intensity exercise mediates comparable increases in exhaled chloride as albuterol in individuals with cystic fibrosis.

Courtney M Wheatley, Sarah E Baker, Mary A Morgan, Marina G Martinez, Bo Liu, Steven M Rowe, Wayne J Morgan, Eric C Wong, Stephen R Karpen, Eric M Snyder

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Respiratory medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Physical activity and exercise training in cystic fibrosis.The Cochrane database of systematic reviews · 2022
    Pooled it
  2. Physical exercise training for cystic fibrosis.The Cochrane database of systematic reviews · 2017
    Pooled it
  3. Trial
  4. Trial
  5. Acquired cystic fibrosis transmembrane conductance regulator dysfunction.Pflugers Archiv : European journal of physiology · 2025
    Review
  6. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.American journal of respiratory and critical care medicine · 2020
    Article
  7. Review
  8. Emerging Concepts and Therapies for Mucoobstructive Lung Disease.Annals of the American Thoracic Society · 2018
    Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Courtney M WheatleyDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA; Division of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA. Electronic address: wheatley.courtney@mayo.edu.
Sarah E BakerDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA; Department of Anesthesiology, Mayo Clinic, Rochester, MN, USA. Electronic address: baker.sarah@mayo.edu.
Mary A MorganDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: uagrad06@gmail.com.
Marina G MartinezDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA; Department of Neurology, University of Arizona, Tucson, AZ, USA. Electronic address: mgm2@email.arizona.edu.
Bo LiuDepartment of Medicine, University of Alabama, Birmingham, AL, USA. Electronic address: bliu@peds.uab.edu.
Steven M RoweDepartment of Medicine, University of Alabama, Birmingham, AL, USA. Electronic address: smrowe@uab.edu.
Wayne J MorganDepartment of Pediatrics- Pulmonology, Allergy and Immunology, University of Arizona, Tucson, AZ, USA. Electronic address: wjmorgan@arc.arizona.edu.
Eric C WongDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: ecwong47@gmail.com.
Stephen R KarpenDepartment of Pharmacy Practice & Science, University of Arizona, Tucson, AZ, USA. Electronic address: karpen@pharmacy.arizona.edu.
Eric M SnyderDepartment of Kinesiology, University of Minnesota, Minneapolis, MN, USA. Electronic address: esnyder@umn.edu.
University of Arizona · USMayo Clinic in Arizona · USUniversity of Alabama at Birmingham · USUniversity of Minnesota · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI AMIT GAGGAR · 2007 to 2026
$23.0M
Gene-by-Gene Interactions and Lung Fluid Balance in Patients with Heart FailureR01HL108962 · NHLBI · UNIVERSITY OF MINNESOTA · PI SNYDER, ERIC M · 2011 to 2016
$2.2M
NHLBI NIH HHS HL108962-01NHLBI NIH HHS R01 HL108962NIDDK NIH HHS P30 DK072482
6 · The paper itself

Abstract

rationaleDespite the demonstrated advantageous systemic changes in response to regular exercise for individuals with cystic fibrosis (CF), exercise is still viewed as an elective rather than a vital component of therapy, and it is likely that these benefits extend to and are partially mediated by exercise-induced changes in ion regulation.

objectiveWe sought to determine if exercise could provide comparable improvements in ion regulation in the CF lung as albuterol, measured using exhaled breath condensate (EBC) collection and nasal potential difference (NPD).

methodsFourteen CF (13-42 yrs.) and sixteen healthy (18-42 yrs.) subjects completed a randomized crossover study of albuterol and submaximal exercise. EBC was collected at baseline, 30- and 60-min post-albuterol administration, and at baseline and during three separate 15 min cycling exercise bouts at low, moderate, and vigorous intensity (25, 50 and 65% of the maximum workload, respectively). NPD was performed at 30- and 80-min post albuterol or following moderate and vigorous intensity exercise.

resultsCF subjects had lower EBC Cl(-), but no difference in EBC Na(+) at baseline when compared to healthy subjects. EBC Cl(-) increased four-fold with moderate exercise which was similar to that seen 60-min post albuterol administration for CF subjects. Neither exercise nor albuterol altered EBC Na(+). The change in NPD voltage with amiloride (ΔAmil) was greater and there was minimal Cl(-) secretion (ΔTCC) seen at baseline in the CF compared to the healthy subjects. ΔAmil was greater with both albuterol and exercise when compared to baseline within both CF and healthy groups, but there was no significant difference in the ΔTCC response with either treatment.

conclusionBoth exercise and albuterol can alter ion regulation increasing Cl(-) secretion to a significant and similar degree in individuals with CF.

Indexed as

AdolescentAdrenergic beta-2 Receptor AgonistsAdultAlbuterolChloridesCross-Over StudiesCystic FibrosisDose-Response Relationship, DrugExercise TherapyExercise ToleranceFemaleHumansMaleTreatment OutcomeYoung AdultAdrenergic beta-2 Receptor AgonistsAlbuterolChloridesAirway surface liquidBeta-2 adrenergic receptor (ADBR2)Epithelial sodium channels (ENaC)Exhaled breath condensate (EBC)Nasal potential difference (NPD)Purinergic receptor (P2Y(2))

Identifiers

PMID26077038
PMCPMC4941831
OpenAlexW1816951821

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.